Activation of human pro-urokinase by unrelated proteases secreted by Pseudomonas aeruginosa

Biochemical Journal

Volumn 428, Issue 3, 2010, Pages 473-482

  Beaufort, Nathalie ^a,b   Seweryn, Paulina ^a   De Bentzmann, Sophie ^c   Tang, Aihua ^d   Kellermann, Josef ^e   Grebenchtchikov, Nicolai ^f   Schmitt, Manfred ^a   Sommerhoff, Christian P ^g   Pidard, Dominique ^b   Magdolen, Viktor ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSERM   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^e MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bacterial invasion; Human urokinase; LasB; Plasminogen activation system; Protease IV; Pseudomonas aeruginosa

Indexed keywords

ACTIVATION SYSTEMS; ANGIOSTATIN; BACTERIAL INVASION; DIFFERENT SUBSTRATES; EXTRACELLULAR; MATRIX METALLOPROTEINASE-2; METALLO-PROTEASE; PATHOGENIC BACTERIUM; PLASMINOGEN ACTIVATOR INHIBITOR-1; PROTEOLYTIC SYSTEM; PS. AERUGINOSA; PSEUDOMONAS AERUGINOSA; RECOMBINANT PROTEIN EXPRESSION; SECRETOME; SERINE PROTEASE; THERMOLYSIN;

AMINO ACIDS; BACTERIA; BACTERIOLOGY; ENZYME ACTIVITY; ENZYME INHIBITION; ESCHERICHIA COLI; GENE ENCODING; PHOSPHATASES;

CHEMICAL ACTIVATION;

ANGIOSTATIN; BACTERIAL PROTEASE; BACTERIAL PROTEIN; GELATINASE A; LASB PROTEIN; METALLOPROTEINASE; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROUROKINASE; RECOMBINANT PROTEIN; THERMOLYSIN; UNCLASSIFIED DRUG; PEPTIDE HYDROLASE; SARUPLASE; UROKINASE;

ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; HUMAN TISSUE; HYPOTHESIS; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; PURIFICATION; ENZYME SPECIFICITY; ENZYMOLOGY; GENETICS; KINETICS; METABOLISM;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; PSEUDOMONAS AERUGINOSA;

BACTERIAL PROTEINS; HUMANS; KINETICS; PEPTIDE HYDROLASES; PLASMINOGEN; PSEUDOMONAS AERUGINOSA; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 77954918983     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20091806     Document Type: Article

References (54)

1. Barrett, A. J. (2004) Bioinformatics of proteases in the MEROPS database. Curr. Opin. Drug Discov. Dev. 7, 334-341
2. Kukkonen, M. and Korhonen, T. K. (2004) The omptin family of enterobacterial surface proteases/adhesins: from housekeeping in Escherichia colito systemic spread of Yersinia pestis. Int. J. Med. Microbiol. 294, 7-14
3. Travis, J., Potempa, J. and Maeda, H. (1995) Are bacterial proteinases pathogenic factors? Trends Microbiol. 3, 405-407
4. Supuran, C. T., Scozzafava, A. and Clare, B. W. (2002) Bacterial protease inhibitors. Med. Res. Rev. 22, 329-372
5. Coombes, B. K., Valdez, Y. and Finlay, B. B. (2004) Evasive maneuvers by secreted bacterial proteins to avoid innate immune responses. Curr. Biol. 14, R856-R867
6. Potempa, J. and Pike, R. N. (2009) Corruption of innate immunity by bacterial proteases. J. Innate Immun. 1, 70-87
7. Lahteenmaki, K., Edelman, S. and Korhonen, T. K. (2005) Bacterial metastasis: the host plasminogen system in bacterial invasion. Trends Microbiol. 13, 79-85
8. Bergmann, S. and Hammerschmidt, S. (2007) Fibrinolysis and host response in bacterial infections. Thromb. Haemostasis 98, 512-520
9. Degen, J. L., Bugge, T. H. and Goguen, J. D. (2007) Fibrin and fibrinolysis in infection and host defense. J. Thromb. Haemostasis 5, 24-31
10. Castellino, F. J. and Ploplis, V. A. (2005) Structure and function of the plasminogen/plasmin system. Thromb. Haemostasis 93, 647-654
11. Lijnen, H. R. (2001) Elements of the fibrinolytic system. Ann. N.Y. Acad. Sci. 936, 226-236
12. Ellis, V. (2003) Plasminogen activation at the cell surface. Curr. Top. Dev. Biol. 54, 263-312
13. Beaufort, N., Wojciechowski, P., Sommerhoff, C. P., Szmyd, G., Dubin, G., Eick, S., Kellermann, J., Schmitt, M., Potempa, J. and Magdolen, V. (2008) The human fibrinolytic system is a target for the staphylococcal metalloprotease aureolysin. Biochem. J. 410, 157-165 (Pubitemid 351300335)
14. Pier, G. B. and Ramphal, R. (2005) Pseudomonas aeruginosa. In Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, 6th edn (Mandell, G. L., Bennett, J. E. and Dolin, R., eds), pp. 2587-2615, Churchill Livingstone, London
15. Caballero, A. R., Moreau, J. M., Engel, L. S., Marquart, M. E., Hill, J. M. and O'Callaghan, R. J. (2001) Pseudomonas aeruginosa protease IV enzyme assays and comparison to other Pseudomonasproteases. Anal. Biochem. 290, 330-337
16. Matsumoto, K. (2004) Role of bacterial proteases in pseudomonal and serratial keratitis. Biol. Chem. 385, 1007-1016
17. Kida, Y., Higashimoto, Y., Inoue, H., Shimizu, T. and Kuwano, K. (2008) A novel secreted protease from Pseudomonas aeruginosa activates NF-κB through protease-activated receptors. Cell. Microbiol. 10, 1491-1504
18. Marquart, M. E., Caballero, A. R., Chomnawang, M., Thibodeaux, B. A., Twining, S. S. and O'Callaghan, R. J. (2005) Identification of a novel secreted protease from Pseudomonas aeruginosa that causes corneal erosions. Invest. Ophthalmol. Visual Sci. 46, 3761-3768
19. Tang, A., Marquart, M. E., Fratkin, J. D., McCormick, C. C., Caballero, A. R., Gatlin, H. P. and O'Callaghan, R. J. (2009) Properties of PASP: a Pseudomonasprotease capable of mediating corneal erosions. Invest. Ophthalmol. Visual Sci. 50, 3794-3801
20. Thayer, M. M., Flaherty, K. M. and McKay, D. B. (1991) Three-dimensional structure of the elastase of Pseudomonas aeruginosa at 1.5-Å resolution. J. Biol. Chem. 266, 2864-2871
21. Banbula, A., Potempa, J., Travis, J., Fernandez-Catalan, C., Mann, K., Huber, R., Bode, W. and Medrano, F. (1998) Amino-acid sequence and three-dimensional structure of the Staphylococcus aureus metalloproteinase at 1.72 Å resolution. Structure 6, 1185-1193 (Pubitemid 28434120)
22. da Silva, C. M., de Abreu Vidipo, L., Nishi, R. and Cristina Plotkowski, M. (2004) Binding of plasminogen to Pseudomonas aeruginosa results in formation of surface-associated plasmin and enhanced bacterial invasiveness. Microb. Pathog. 36, 59-66
23. Engel, L. S., Hill, J. M., Caballero, A. R., Green, L. C. and O'Callaghan, R. J. (1998) Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa. J. Biol. Chem. 273, 16792-16797
24. Grebenchtchikov, N., Sweep, C. G., Geurts-Moespot, A., Piffanelli, A., Foekens, J. A. and Benraad, T. J. (2002) An ELISA avoiding interference by heterophilic antibodies in the measurement of components of the plasminogen activation system in blood. J. Immunol. Methods 268, 219-231
25. Luther, T., Magdolen, V., Albrecht, S., Kasper, M., Riemer, C., Kessler, H., Graeff, H., Muller, M. and Schmitt, M. (1997) Epitope-mapped monoclonal antibodies as tools for functional and morphological analyses of the human urokinase receptor in tumor tissue. Am. J. Pathol. 150, 1231-1244
26. Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., Hickey, M. J., Brinkman, F. S., Hufnagle, W. O., Kowalik, D. J., Lagrou, M. et al. (2000) Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 406, 959-964
27. McIver, K. S., Kessler, E., Olson, J. C. and Ohman, D. E. (1995) The elastase propeptide functions as an intramolecular chaperone required for elastase activity and secretion in Pseudomonas aeruginosa. Mol. Microbiol. 18, 877-889
28. Fondard, O., Detaint, D., Iung, B., Choqueux, C., Adle-Biassette, H., Jarraya, M., Hvass, U., Couetil, J. P., Henin, D., Michel, J. B. et al. (2005) Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors. Eur. Heart J. 26, 1333-1341
29. Jameson, G. W., Roberts, D. V., Adams, R. W., Kyle, W. S. and Elmore, D. T. (1973) Determination of the operational molarity of solutions of bovine α-chymotrypsin, trypsin, thrombin and Factor Xa by spectrofluorimetric titration. Biochem. J. 131, 107-117
30. Liu, J. N. and Gurewich, V. (1993) The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activator. Blood 81, 980-987
31. Castro, M. J., Kingston, I. B. and Anderson, S. (1995) A spectrophotometric assay for the determination of the catalytic efficiency of plasminogen activators using a slowly hydrolyzed plasmin substrate. Anal. Biochem. 226, 225-231
32. Leduc, D., Beaufort, N., de Bentzmann, S., Rousselle, J. C., Namane, A., Chignard, M. and Pidard, D. (2007) The Pseudomonas aeruginosa LasB metalloproteinase regulates the human urokinase-type plasminogen activator receptor through domain-specific endoproteolysis. Infect. Immun. 75, 3848-3858
33. Jaffar-Bandjee, M. C., Lazdunski, A., Bally, M., Carrere, J., Chazalette, J. P. and Galabert, C. (1995) Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa. J. Clin. Microbiol. 33, 924-929
34. O'Callaghan, R. J., Engel, L. S., Hobden, J. A., Callegan, M. C., Green, L. C. and Hill, J. M. (1996) Pseudomonaskeratitis: the role of an uncharacterized exoprotein, protease IV, in corneal virulence. Invest. Ophthalmol. Visual Sci. 37, 534-543
35. Wilderman, P. J., Vasil, A. I., Johnson, Z., Wilson, M. J., Cunliffe, H. E., Lamont, I. L. and Vasil, M. L. (2001) Characterization of an endoprotease (PrpL) encoded by a PvdS-regulated gene in Pseudomonas aeruginosa. Infect. Immun. 69, 5385-5394
36. Elliott, Jr, B. W. and Cohen, C. (1986) Isolation and characterization of a lysine-specific protease from Pseudomonas aeruginosa. J. Biol. Chem. 261, 11259-11265
37. Caballero, A., Thibodeaux, B., Marquart, M., Traidej, M. and O'Callaghan, R. (2004) Pseudomonaskeratitis: protease IV gene conservation, distribution, and production relative to virulence and other Pseudomonasproteases. Invest. Ophthalmol. Visual Sci. 45, 522-530
38. Debela, M., Magdolen, V., Grimminger, V., Sommerhoff, C., Messerschmidt, A., Huber, R., Friedrich, R., Bode, W. and Goettig, P. (2006) Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site. J. Mol. Biol. 362, 1094-1107
39. Debela, M., Goettig, P., Magdolen, V., Huber, R., Schechter, N. M. and Bode, W. (2007) Structural basis of the zinc inhibition of human tissue kallikrein 5. J. Mol. Biol. 373, 1017-1031
40. Traidej, M., Marquart, M. E., Caballero, A. R., Thibodeaux, B. A. and O'Callaghan, R. J. (2003) Identification of the active site residues of Pseudomonas aeruginosa protease IV: importance of enzyme activity in autoprocessing and activation. J. Biol. Chem. 278, 2549-2553
41. Traidej, M., Caballero, A. R., Marquart, M. E., Thibodeaux, B. A. and O'Callaghan, R. J. (2003) Molecular analysis of Pseudomonas aeruginosa protease IV expressed in Pseudomonas putida. Invest. Ophthalmol. Visual Sci. 44, 190-196
42. Boudier, C., Gils, A., Declerck, P. J. and Bieth, J. G. (2005) The conversion of active to latent plasminogen activator inhibitor-1 is an energetically silent event. Biophys. J. 88, 2848-2854
43. de Bentzmann, S., Polette, M., Zahm, J. M., Hinnrasky, J., Kileztky, C., Bajolet, O., Klossek, J. M., Filloux, A., Lazdunski, A. and Puchelle, E. (2000) Pseudomonas aeruginosa virulence factors delay airway epithelial wound repair by altering the actin cytoskeleton and inducing overactivation of epithelial matrix metalloproteinase-2. Lab. Invest. 80, 209-219
44. Nagano, T., Hao, J. L., Nakamura, M., Kumagai, N., Abe, M., Nakazawa, T. and Nishida, T. (2001) Stimulatory effect of pseudomonal elastase on collagen degradation by cultured keratocytes. Invest. Ophthalmol. Visual Sci. 42, 1247-1253
45. Urano, T., Ihara, H., Umemura, K., Suzuki, Y., Oike, M., Akita, S., Tsukamoto, Y., Suzuki, I. and Takada, A. (2001) The profibrinolytic enzyme subtilisin NAT purified from Bacillus subtilis cleaves and inactivates plasminogen activator inhibitor type 1. J. Biol. Chem. 276, 24690-24696
46. Kunert, A., Losse, J., Gruszin, C., Huhn, M., Kaendler, K., Mikkat, S., Volke, D., Hoffmann, R., Jokiranta, T. S., Seeberger, H. et al. (2007) Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein. J. Immunol. 179, 2979-2988
47. Ullberg, M., Kronvall, G., Karlsson, I. and Wiman, B. (1990) Receptors for human plasminogen on Gram-negative bacteria. Infect. Immun. 58, 21-25
48. Chavakis, T., Athanasopoulos, A., Rhee, J. S., Orlova, V., Schmidt-Woll, T., Bierhaus, A., May, A. E., Celik, I., Nawroth, P. P. and Preissner, K. T. (2005) Angiostatin is a novel anti-inflammatory factor by inhibiting leukocyte recruitment. Blood 105, 1036-1043
49. Hart, D. A. and Woods, D. E. (1994) Human urokinase, a serine proteinase, potentiates the in vitro growth of micro-organisms which commonly infect burn patients. J. Med. Microbiol. 41, 264-271
50. Heys, S. J., Orton, S. L. and Allison, D. G. (1999) Effect of urokinase on the extracellular virulence properties of Pseudomonas aeruginosa and Burkholderia cepacia. J. Basic Microbiol. 39, 17-24
51. Appella, E., Robinson, E. A., Ullrich, S. J., Stoppelli, M. P., Corti, A., Cassani, G. and Blasi, F. (1987) The receptor-binding sequence of urokinase: a biological function for the growth-factor module of proteases. J. Biol. Chem. 262, 4437-4440
52. Smith, L., Rose, B., Tingpej, P., Zhu, H., Conibear, T., Manos, J., Bye, P., Elkins, M., Willcox, M., Bell, S. et al. (2006) Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis. J. Med. Microbiol. 55, 1641-1644
53. Bode, W. and Huber, R. (1976) Induction of the bovine trypsinogen-trypsin transition by peptides sequentially similar to the N-terminus of trypsin. FEBS Lett. 68, 231-236
54. Comellas-Bigler, M., Maskos, K., Huber, R., Oyama, H., Oda, K. and Bode, W. (2004) 1.2 Å crystal structure of the serine carboxyl proteinase pro-kumamolisin; structure of an intact pro-subtilase. Structure 12, 1313-1323 (Pubitemid 38900773)